USFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy Farhat Nasim15 Feb 2025 10:45 AM ISTEvrysdi is the only non-invasive disease-modifying treatment for SMA.
Roflumilast foam useful in patients with moderate to severe seborrheic dermatitis, reveals phase 3 trial Dr. Kamal Kant Kohli12 Jun 2022 7:30 PM ISTWESTLAKE VILLAGE, Calif: Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful...
Zuranolone found effective for postpartum depression in phase 3 study Dr. Kamal Kant Kohli6 Jun 2022 9:15 AM ISTCAMBRIDGE, Mass: Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that the Phase 3 SKYLARK Study of zuranolone,...
Investigational JAK inhibitor found safe, effective in moderate to severe alopecia areata in phase 3 study Dr. Kamal Kant Kohli26 May 2022 8:00 PM ISTAlopecia areata is an autoimmune disorder that results in patchy or complete scalp hair loss. CTP-543 is an investigational oral selective inhibitor...
Dasiglucagon cuts IV glucose requirement in Pediatric Patients with Congenital Hyperinsulinism: Phase 3 Trial Dr. Kamal Kant Kohli20 May 2022 7:45 PM ISTreducing the requirement for IV glucose
Sun Pharmaceuticals to establish ophthalmic business in the US Pooja Bhatia Bhatia17 Sept 2015 12:56 PM ISTDrug major Sun Pharmaceuticals has set its eye on the branded ophthalmic business in the US with the recent acquisition of InSite Vision Inc, a US...
